Free Shipping On Any Order Free UPS 2nd Day Air Shipping On Orders Over $200 Free UPS Next Day Air Shipping On Orders Over $400
Back to Shop

Retatrutide (1 Vial)

Price range: $39.99 through $229.99

Buy Retatrutide (1 Vial) — research-grade triple-agonist peptide targeting GLP-1, GIP, and glucagon receptors. 99%+ purity, US manufactured, lot COA published on this page. Available in 5 mg–60 mg sizes.

Subscribe to several peptides at once →
Bundle & Save

Vials count across your whole order — mix any peptides and sizes.

40% OFF Need 10+ vials? Build your own kit — 40% off every vial

For laboratory and research use only. This product is not a drug, food, or cosmetic and is not for human or animal consumption. It is not intended to diagnose, treat, cure, or prevent any disease. These statements have not been evaluated by the FDA. Sold solely to qualified researchers and licensed laboratories. Certificate of Analysis available on request.

SKU: PSP-RETA Category: Brand:
Research dosage guide

Retatrutide protocol reference

What the published research and common laboratory protocols report for this compound, in one place. Figures are a reference for designing a study, not instructions.

Research use only
Typical research dose 2 mg to start, +2 mg every 4 weeks, up to 12 mg
Frequency Once weekly
Route Subcutaneous
Timing Same day each week; rotate abdomen / thigh / upper arm.
Protocol length ~20 weeks to reach 12 mg; trials ran 48–80 weeks
Storage Refrigerate at 2–8 °C after mixing and use within 28 days. Keep the lyophilized vial frozen (−20 °C) or refrigerated until use.

Reconstitution & syringe units

Units are for a standard U-100 insulin syringe (100 units = 1 mL). Add the water slowly down the inside of the vial, swirl gently — never shake — and refrigerate.

VialAdd BAC waterConcentration2 mg dose4 mg dose8 mg dose
5MG2.5 mL2 mg/mL100 units200 units (2 draws)—
10MG2.5 mL4 mg/mL50 units100 units200 units (2 draws)
15MG2.5 mL6 mg/mL33 units67 units133 units (2 draws)
20MG2.5 mL8 mg/mL25 units50 units100 units
30MG2.5 mL12 mg/mL17 units33 units67 units
40MG2.5 mL16 mg/mL13 units25 units50 units
50MG2.5 mL20 mg/mL10 units20 units40 units
60MG2.5 mL24 mg/mL8.3 units17 units33 units

Over 100 units is more than one full 1 mL (100-unit) syringe — split the dose across the number of draws shown.

Different water volume? Use the dosage calculator — it does the units for any concentration.

Mind the injection volume at the higher doses — use a stronger concentration or split sites rather than injecting more than ~1 mL.

For laboratory and research use only. This product is not a drug, food, cosmetic or dietary supplement and is not for human or animal consumption. The figures above summarise published studies and common research protocols; they are not medical advice or instructions for use. These statements have not been evaluated by the FDA.

Description

Buy retatrutide (1 vial) from PSPeptides — a research-grade triple-agonist peptide that activates the GLP-1, GIP, and glucagon receptors from a single 39-amino-acid sequence. Every vial is lyophilized, US manufactured, and verified at 99%+ purity by independent HPLC and mass spectrometry. When you buy retatrutide here, you choose from eight sizes between 5 mg and 60 mg, all drawn from the same tested quality system.

What Is Retatrutide (LY3437943)?

Retatrutide, developed under the code LY3437943, is a once-weekly peptide engineered to engage three incretin-family receptors at once. The GLP-1 and GIP components reduce energy intake, while the glucagon component raises energy expenditure — a combination that single and dual agonists cannot replicate. Our retatrutide triple-agonist guide explains the pharmacology in depth. Researchers who buy retatrutide from PSPeptides receive the same molecule described in the published literature.

Key Research Applications

Laboratories buy retatrutide for four principal research areas:

  • Body-weight regulation: Phase 2 and Phase 3 trials report the largest mean weight reductions of any incretin-based peptide studied to date.
  • Glycemic control: Retatrutide lowered HbA1c by roughly two percentage points in a 36-week Phase 2 type 2 diabetes trial.
  • Hepatic fat metabolism: A Phase 2a substudy showed liver-fat reductions exceeding 80% at the two highest doses.
  • Energy-expenditure research: Glucagon-receptor activity makes retatrutide a unique probe for thermogenesis and substrate-oxidation studies.

Buy Retatrutide — Product Specifications

Amount5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, or 60 mg per vial (select size above)
Purity99%+ (third-party HPLC and mass spectrometry)
FormLyophilized powder in a single sealed glass vial
Molecular Details39 amino acids, C20 fatty-diacid side chain, molecular weight ≈4,731 Da, CAS 2381089-83-2
StorageLyophilized: −20°C long term or 2–8°C short term; reconstituted: 2–8°C, use within 30 days
TestingBatch-specific COA included
OriginUS manufactured

Additional information

Weight0.03 lbs
Dimensions2 × 2 × 2 in
MG

5MG, 10MG, 15MG, 20MG, 30MG, 40MG, 50MG, 60MG